Germline TP53 pathogenic variants are rare and they represent a condition of predisposition to early-onset breast cancer, which, in association with other tumor types, such as sarcomas and malignant brain tumors, is clinically identified as a manifestation of Li-Fraumeni syndrome. The gene discussed is TP53; the disease is breast carcinoma.